Addiction Research

According to the World Health Organization (WHO), addiction is 'a chronic disease of the central nervous system that is characterized by a loss of control over impulsive behavior that leads to compulsive drug seeking and taking, and to relapses even after months of abstinence'. Addiction is a complex neuroadaptive process, where drugs of abuse alter cellular and molecular aspects of neural function. The brain circuits mediating the various behavioral effects of these drugs are rendered more, or less, responsive to those effects.

Addiction Research Products Targets

Products for Addiction Research - Page 33

  1. Cat.No. Product Name Information/Activity
  2. BCC7532 CX 546 CX546 is a selective positive AMPAR modulator; the prototypical ampakine agent. CX 546 chemical structure
  3. BCC6759 Cyclothiazide 2259-96-3 Cyclothiazide chemical structure
  4. BCC5951 PEPA PEPA is an allosteric modulator of AMPA receptors; binds to the GluA2o and GluA3o LBDs and can be utilized as an indicator of AMPA receptor heterogeneity. PEPA chemical structure
  5. BCC6322 PF 4778574 PF-4778574 is a positive allosteric modulation of AMPA receptor with EC50 of 45 to 919 nM in differenct cells. PF 4778574 chemical structure
  6. BCC6081 S 18986 S 18986 is a selective, orally active, brain penetrant positive allosteric modulator of AMPA-type receptors. S 18986 shows cognitive enhancing properties in rodents. S 18986 activates the release of noradrenaline and acetylcholine in rat hippocampus and enhances rat memory in object-recognition tests. S 18986 chemical structure
  7. BCC4219 Aniracetam Aniracetam(Ro 13-5057) is a nootropics and neuroprotective drug, which is selectively modulates the AMPA receptor and nAChR. Aniracetam chemical structure
  8. BCC6974 IDRA 21 22503-72-6 IDRA 21 chemical structure
  9. BCC5787 pep2-AVKI 1315378-69-8 pep2-AVKI chemical structure
  10. BCC5786 pep2-EVKI 1315378-67-6 pep2-EVKI chemical structure
  11. BCC5782 pep2m 243843-42-7 pep2m chemical structure

Items 321 to 330 of 509 total